Between Feb 24 and Mar 2, Raffles Medical Group Raffles Medical: BSL +0.87% executive chairman and non-independent director Loo Choon Yong acquired 4.5 million shares of the private healthcare provider for a consideration of S$1.77 million. At an average price of S$1.17 per share, this increased Dr Loo' s direct interest from 10.43 per cent to 10.68 per cent.

 

This was triple the amount of shares that he acquired in February 2021 at an average price of S$1.02 per share that followed the release of the FY20 financials.

 

On Feb 24, executive and non-independent director Sarah Lu Qinghui also acquired 1.5 million shares of the group at an average price of S$1.18 per share. Acquired through S & D Holdings, this increased her deemed interest in the company from 3.29 per cent to 3.37 per cent.

 

She is the daughter of Dr Loo and a shareholder of S & D Holdings, so this acquisition also increased the deemed interest of Dr Loo by 1.5 million shares.

 

Dr Lu was first appointed a director of Raffles Medical Group in February 2018 at which time she maintained a 3.24 per cent deemed interest in the company.

 

On Feb 21, Raffles Medical Group reported that its profit after tax and minority interest grew 27.7 per cent to S$84.2 million in FY21 (ended Dec 31) from S$65.9 million in FY20.

 

Dr Loo noted that with RafflesHospitalShanghai operational, the group now has hospitals in 3 major cities in China.

 

With this addition to its network of medical facilities and services in the region, the group is able to serve even more local and international patients with the Raffles brand of quality healthcare services.

 

The group' s network includes 3 tertiary hospitals and more than 100 multi-disciplinary clinics, offering services such as health screening, specialist care, and diagnostic radiology, dental and traditional Chinese medicine.

 

The group was also active in buying back its shares after reporting its FY21 results, buying back 5 million shares since it reported its FY21.

 

Dr Loo co-founded the group in 1976 and was appointed to his current position in 1997 when the group was listed.

 

He is also the chairman of the Asian Medical Foundation and Raffles Health Insurance, as well as director of International SOS (MC Holdings).

 

Dr Loo' s total interest in Raffles Medical Group is 52.73 per cent, a stake which has gradually increased from 51.93 per cent at the end of 2014.

 

Raffles Medical Group also bought back 2.9 million shares over the 5 sessions at an average price of S$1.16 per share.

Between Feb 24 and Mar 2, Raffles Medical Group Raffles Medical: BSL +0.87% executive chairman and non-independent director Loo Choon Yong acquired 4.5 million shares of the private healthcare provider for a consideration of S$1.77 million. At an average price of S$1.17 per share, this increased Dr Loo' s direct interest from 10.43 per cent to 10.68 per cent.

 

This was triple the amount of shares that he acquired in February 2021 at an average price of S$1.02 per share that followed the release of the FY20 financials.

 

On Feb 24, executive and non-independent director Sarah Lu Qinghui also acquired 1.5 million shares of the group at an average price of S$1.18 per share. Acquired through S & D Holdings, this increased her deemed interest in the company from 3.29 per cent to 3.37 per cent.

 

She is the daughter of Dr Loo and a shareholder of S & D Holdings, so this acquisition also increased the deemed interest of Dr Loo by 1.5 million shares.

 

Dr Lu was first appointed a director of Raffles Medical Group in February 2018 at which time she maintained a 3.24 per cent deemed interest in the company.

 

On Feb 21, Raffles Medical Group reported that its profit after tax and minority interest grew 27.7 per cent to S$84.2 million in FY21 (ended Dec 31) from S$65.9 million in FY20.

 

Dr Loo noted that with RafflesHospitalShanghai operational, the group now has hospitals in 3 major cities in China.

 

With this addition to its network of medical facilities and services in the region, the group is able to serve even more local and international patients with the Raffles brand of quality healthcare services.

 

The group' s network includes 3 tertiary hospitals and more than 100 multi-disciplinary clinics, offering services such as health screening, specialist care, and diagnostic radiology, dental and traditional Chinese medicine.

 

The group was also active in buying back its shares after reporting its FY21 results, buying back 5 million shares since it reported its FY21.

 

Dr Loo co-founded the group in 1976 and was appointed to his current position in 1997 when the group was listed.

 

He is also the chairman of the Asian Medical Foundation and Raffles Health Insurance, as well as director of International SOS (MC Holdings).

 

Dr Loo' s total interest in Raffles Medical Group is 52.73 per cent, a stake which has gradually increased from 51.93 per cent at the end of 2014.

 

Raffles Medical Group also bought back 2.9 million shares over the 5 sessions at an average price of S$1.16 per share.